Synektik (STU:A2P) Piotroski F-Score: 7 (As of Jun. 28, 2026) — 17% Above Median


STU:A2P Synektik SA STU:A2P
85 GF Score
Price €73.85
GF Value €51.60
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Piotroski F-Score?

Synektik STU:A2P +0.89% 85 Piotroski F-Score is 7 as of Jun. 28, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates STU:A2P with a GF Score™ of 85/100 and a GF Value™ of €51.60 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Synektik ranks better than 92.44% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Synektik has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Synektik's Piotroski F-Score or its related term are showing as below:

STU:A2P' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 9
Current: 7

During the past 13 years, the highest Piotroski F-Score of Synektik was 9. The lowest was 3. And the median was 6.

Synektik  (STU:A2P) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Synektik Piotroski F-Score Related Terms


Synektik Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Synektik's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Piotroski F-Score Chart

Synektik Annual Data
Trend Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 6.00 9.00 8.00

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 6.00 7.00

STU:A2P vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Synektik's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synektik Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Synektik's Piotroski F-Score falls into.


STU:A2P
85GF Score
Synektik SA STU:A2P
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 5.524 + 7.203 + 8.146 + 69.038 = €89.9 Mil.
Cash Flow from Operations was -1.172 + 8.493 + 22.623 + -4.432 = €25.5 Mil.
Revenue was 35.93 + 46.412 + 53.107 + 49.662 = €185.1 Mil.
Gross Profit was 13.566 + 17.761 + 18.079 + 18.219 = €67.6 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(88.557 + 93.02 + 113.938 + 141.019 + 113.734) / 5 = €110.0536 Mil.
Total Assets at the begining of this year (Mar25) was €88.6 Mil.
Long-Term Debt & Capital Lease Obligation was €5.8 Mil.
Total Current Assets was €74.3 Mil.
Total Current Liabilities was €60.5 Mil.
Net Income was 3.901 + 4.407 + 7.717 + 3.362 = €19.4 Mil.

Revenue was 28.881 + 32.879 + 47.319 + 29.047 = €138.1 Mil.
Gross Profit was 10.028 + 11.131 + 14.553 + 10.632 = €46.3 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(75.137 + 81.662 + 87.416 + 112.976 + 88.557) / 5 = €89.1496 Mil.
Total Assets at the begining of last year (Mar24) was €75.1 Mil.
Long-Term Debt & Capital Lease Obligation was €5.7 Mil.
Total Current Assets was €51.9 Mil.
Total Current Liabilities was €37.3 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Synektik's current Net Income (TTM) was 89.9. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Synektik's current Cash Flow from Operations (TTM) was 25.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=89.911/88.557
=1.01528959

ROA (Last Year)=Net Income/Total Assets (Mar24)
=19.387/75.137
=0.25802201

Synektik's return on assets of this year was 1.01528959. Synektik's return on assets of last year was 0.25802201. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Synektik's current Net Income (TTM) was 89.9. Synektik's current Cash Flow from Operations (TTM) was 25.5. ==> 25.5 <= 89.9 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=5.788/110.0536
=0.05259255

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=5.719/89.1496
=0.0641506

Synektik's gearing of this year was 0.05259255. Synektik's gearing of last year was 0.0641506. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=74.322/60.49
=1.2286659

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=51.853/37.266
=1.39142918

Synektik's current ratio of this year was 1.2286659. Synektik's current ratio of last year was 1.39142918. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Synektik's number of shares in issue this year was 8.529. Synektik's number of shares in issue last year was 8.529. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=67.625/185.111
=0.36532135

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=46.344/138.126
=0.33551974

Synektik's gross margin of this year was 0.36532135. Synektik's gross margin of last year was 0.33551974. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=185.111/88.557
=2.09030342

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=138.126/75.137
=1.838322

Synektik's asset turnover of this year was 2.09030342. Synektik's asset turnover of last year was 1.838322. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+0+1+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Synektik has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Synektik (STU:A2P) has a Piotroski F-Score of 7 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Synektik and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Synektik's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Synektik ranks #61 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Synektik's Piotroski F-Score too high?
Synektik's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Synektik's value of 7 is 40% above this industry median. Based on the distribution chart, Synektik ranks #61 out of 807 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Synektik has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Synektik ranks #61 out of 807 companies for Piotroski F-Score. This places Synektik in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Synektik's value of 7 is 40% above this benchmark. Historically, Synektik's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Synektik has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synektik's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Synektik and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synektik's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (STU:A2P) is currently considered Significantly Overvalued. The stock's GF Value™ is €51.60, compared to a current price of €73.85 — trading 43.1% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Synektik's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Synektik (STU:A2P), the current Piotroski F-Score is 7 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (STU:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €73.85 is trading 43.1% above its estimated GF Value™ of €51.60. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for STU:A2P:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: €51.60 vs. price of €73.85 (43.1% above fair value)
  • GF Score™: 85/100 with 7 warning signs
  • Industry Position: 40% above the Medical Devices & Instruments median (#61 of 807)

No single metric tells the full story. See the STU:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synektik Business Description

Other Exchanges SNT:PolandA2P:Germany
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
85GF Score

Get the complete analysis for STU:A2P

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€73.85
Price
€51.60
GF Value